Dr. MiltieAtlas by Dr. Miltie™Nationwide Grant Intelligence
Verification Pending — official Grants.gov candidate (posted)
PAR-25-175

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Official Grants.gov opportunity PAR-25-175 from National Institutes of Health. Requires full eligibility, amount, controlling deadline, award-type and duplication QA before publication.

FundingOfficial federal synopsis lists an award ceiling of 500,000; applicant-level applicability requires full-NOFO review.
Deadline2028-01-07 (official deadline clock time and time zone must be checked in NOFO)
Last verifiedAtlas review
Required next actionReview the official full announcement, amendments and submission portal requirements before applying.

Broad Eligibility

Special district governments; Native American tribal governments (Federally recognized); County governments; Public and State controlled institutions of higher education; City or township governments; Public housing authorities/Indian housing authorities; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Private institutions of higher education; Independent school districts; Others (see text field entitled "Additional Information on Eligibility" for clarification); State governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; Small businesses

Official funding announcement — preliminary draft

Funder: National Institutes of Health

Opportunity number: PAR-25-175

Official listed status: posted

Closing information: 2028-01-07 (official deadline clock time and time zone must be checked in NOFO)

Award disclosure: Official federal synopsis lists an award ceiling of 500,000; applicant-level applicability requires full-NOFO review.

Applicant categories in federal synopsis: Special district governments; Native American tribal governments (Federally recognized); County governments; Public and State controlled institutions of higher education; City or township governments; Public housing authorities/Indian housing authorities; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Private institutions of higher education; Independent school districts; Others (see text field entitled "Additional Information on Eligibility" for clarification); State governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; Small businesses

Federal synopsis

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.

Draft intake record. Eligibility, program terms, current amendments and applicant ceiling must be independently verified before publishing.

Official Grants.gov opportunity and NOFO

From Funding to Implementation · School Health Solution

Turn school-health funding into a clinically capable care model.

Dr. Miltie N9+ can support clinician-directed remote exams in school settings, helping care teams move beyond video-only encounters when a funded program calls for stronger pediatric access.

Explore School-Based Virtual Exams ↗Dr. Miltie solves the healthcare problem. Atlas helps fund the solution.
Source verificationOfficial government source · www.grants.govAtlas last verified this record during its latest review. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗